Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

2013 ◽  
Vol 2 (4) ◽  
pp. 358-366 ◽  
Author(s):  
Nobuko Matsushima ◽  
Frank Lee ◽  
Toshiyuki Sato ◽  
Daniel Weiss ◽  
Jeanne Mendell
Keyword(s):  
Healthy Subjects ◽  
Factor Xa ◽  
Factor Xa Inhibitor

Pharmacokinetic/Pharmacodynamic Relationships for Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Subjects

2006 ◽  
Vol 46 (1) ◽  
pp. 45-51 ◽  
Author(s):  
Anne Paccaly ◽  
Annke Frick ◽  
Marie-Laure Ozoux ◽  
Valeria Chu ◽  
Ronald Rosenburg ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Factor Xa ◽  
Factor Xa Inhibitor ◽  
Direct Factor

Pharmacokinetics, Biotransformation, and Mass Balance of Edoxaban, a Selective, Direct Factor Xa Inhibitor, in Humans

2012 ◽  
Vol 40 (12) ◽  
pp. 2250-2255 ◽  
Author(s):  
Mohinder S. Bathala ◽  
Hiroshi Masumoto ◽  
Toshihiro Oguma ◽  
Ling He ◽  
Chris Lowrie ◽  
...  
Keyword(s):  
Mass Balance ◽  
Factor Xa ◽  
Factor Xa Inhibitor ◽  
Direct Factor

Betrixaban – the next direct factor Xa inhibitor?

2016 ◽  
Vol 9 (12) ◽  
pp. 1111-1117 ◽  
Author(s):  
Martin Thoenes ◽  
Joan Minguet ◽  
Karin Bramlage ◽  
Peter Bramlage ◽  
Carmen Ferrero
Keyword(s):  
Factor Xa ◽  
Factor Xa Inhibitor ◽  
Direct Factor
Sign in / Sign up

Export Citation Format

Share Document